The downgrade is a result of several factors, including the health system’s declining patient volume, competitive service area, operating losses through the third quarter of fiscal year 2017 and higher leverage following expected debt for a capital project. Moody’s also acknowledged the health systems strong market position and healthy liquidity metrics.
The outlook is negative; reflecting the challenges Summa Health must overcome in order to achieve operating margin improvement.
More articles on healthcare finance:
6 recent hospital, health system outlook and credit rating actions
U of Arizona Cancer Center receives $2M to study selenium supplementation
10 hospitals seeking RCM talent
